These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7924883)

  • 21. Effect of troglitazone on serum gamma-glutamyltransferase activity and plasma t-PA/PAI-1 complex in type 2 diabetic patients.
    Koh H; Akiyama Y; Yui K
    Arzneimittelforschung; 2006; 56(4):288-94. PubMed ID: 16724515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P; Kotuličová D; Staško J; Kubisz P
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients.
    Testa R; Bonfigli AR; Sirolla C; Pieri C; Marra M; Antonicelli R; Manfrini S; Compagnucci P; Testa I
    Diabetes Nutr Metab; 1999 Dec; 12(6):400-6. PubMed ID: 10782561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitus.
    Grant MB; Fitzgerald C; Guay C; Lottenberg R
    Metabolism; 1989 Sep; 38(9):901-7. PubMed ID: 2505017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Mesa J; Simó R
    Thromb Res; 2000 Jul; 99(2):119-27. PubMed ID: 10946085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
    Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
    Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.
    Polac I; Stachowiak G; Jedrzejczyk S; Stetkiewics T; Sobieszczanska S; Pertynski T
    Gynecol Endocrinol; 2003 Apr; 17(2):151-7. PubMed ID: 12744226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Gough SC; Rice PJ; McCormack L; Chapman C; Grant PJ
    Diabet Med; 1993; 10(7):638-42. PubMed ID: 8403825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
    Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study.
    Simpson AJ; Booth NA; Moore NR; Lewis SJ; Gray RS
    Acta Diabetol; 1999 Sep; 36(3):155-8. PubMed ID: 10664320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A; Galar M
    Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complications.
    Testa R; Bonfigli AR; Pieri C; Marra M; Sirolla C; Manfrini S; Testa I
    Int J Clin Lab Res; 1998; 28(3):187-91. PubMed ID: 9801931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
    Auwerx J; Bouillon R; Collen D; Geboers J
    Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
    Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
    Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.